tirzepatide and gallstones Gallstones: What You Need to Know Wegovy and gallbladder Guide: Risks

But once youre on a GLP-1, everything shifts

As a dual GLP-1 and GIP receptor agonist, tirzepatide activates two incretin pathways simultaneously

This timeline is based on aggregate data from 338 Phase 2 clinical trial participants

News release from Indiana Governor Mike Brauns office: Governor Braun Announces State Medicaid Program Will Now Cover GLP-1 Treatments for Eligible Beneficiaries Indiana Will Participate in CMMI BALANCE Demonstration to Expand Access to Essential Obesity Medication Indianapolis, Indiana (July 30, 2026) Indiana Governor Mike Braun today directed the Indiana Family and Social Services Administration (FSSA) to participate in the Center for Medicare and Medicaid Innovations BALANCE demonstration, expanding access to select GLP-1 medications for eligible Indiana Medicaid members living with obesity

This effect was followed by the increase in substrate fluorescent or GSH transport and decreasing of GSSG efflux

Nature Medicine, 30 (7), 20492057